Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.

Petit, Géraldine H; Berkovich, Elijahu; Hickery, Mark; Kallunki, Pekka; Fog, Karina; Fitzer-Attas, Cheryl; Brundin, Patrik

Petit, Géraldine H; Berkovich, Elijahu; Hickery, Mark; Kallunki, Pekka; Fog, Karina; Fitzer-Attas, Cheryl; Brundin, Patrik.

Affiliation

Petit GH; Neuronal Survival Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC B11, Lund University, Lund, Sweden. geraldine.petit@med.lu.se

PLoS One ; 8(4): e60691, 2013.

Article in En | MEDLINE | ID: mdl-23573275

Subject(s)

Indans/pharmacology; Monoamine Oxidase Inhibitors/pharmacology; Olfaction Disorders/drug therapy; Parkinson Disease/drug therapy; alpha-Synuclein/metabolism; Age Factors; Animals; Disease Models, Animal; Humans; Indans/therapeutic use; Memory, Short-Term; Mice; Mice, Transgenic; Monoamine Oxidase Inhibitors/therapeutic use; Olfactory Bulb/drug effects; Olfactory Bulb/pathology; Smell/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Alpha-Synuclein / Indans / Olfaction Disorders / Monoamine Oxidase Inhibitors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: Sweden Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google